Abstract
Helicobacter spp. represent a proportionately small but significant component of the normal intestinal microflora of animal hosts. Several of these intestinal Helicobacter spp. are known to induce colitis in mouse models, yet the mechanisms by which these bacteria induce intestinal inflammation are poorly understood. To address this question, we performed in vitro co-culture experiments with mouse and human epithelial cell lines stimulated with a selection of Helicobacter spp., including known pathogenic species as well as ones for which the pathogenic potential is less clear. Strikingly, a member of the normal microflora of rodents, Helicobacter muridarum, was found to be a particularly strong inducer of CXC chemokine (Cxcl1/KC, Cxcl2/MIP-2) responses in a murine intestinal epithelial cell line. Time-course studies revealed a biphasic pattern of chemokine responses in these cells, with H. muridarum lipopolysaccharide (LPS) mediating early (24–48 h) responses and live bacteria seeming to provoke later (48–72 h) responses. H. muridarum LPS per se was shown to induce CXC chemokine production in HEK293 cells stably expressing Toll-like receptor 2 (TLR2), but not in those expressing TLR4. In contrast, live H. muridarum bacteria were able to induce NF-κB reporter activity and CXC chemokine responses in TLR2–deficient HEK293 and in AGS epithelial cells. These responses were attenuated by transient transfection with a dominant negative construct to NOD1, and by stable expression of NOD1 siRNA, respectively. Thus, the data suggest that both TLR2 and NOD1 may be involved in innate immune sensing of H. muridarum by epithelial cells. This work identifies H. muridarum as a commensal bacterium with pathogenic potential and underscores the potential roles of ill-defined members of the normal flora in the initiation of inflammation in animal hosts. We suggest that H. muridarum may act as a confounding factor in colitis model studies in rodents.
Introduction
Mouse models of “spontaneous colitis” have been reported to mimic the lesions observed in human inflammatory bowel disease (IBD) [1]. Though the underlying immunological defects conferring host susceptibility to colitis in these models vary, they all depend on the presence of an intestinal microflora for the initiation of disease [1]. The genus Helicobacter contains several intestinal species that have been linked with the development of colitis in mammalian hosts [2]. Two such species, Helicobacter bilis [3] and Helicobacter hepaticus [4], [5], have been shown to induce particularly severe forms of colitis in mice with defects in cytokine or T-cell functions, whereas Helicobacter cinaedi and Helicobacter fennelliae have been associated with colitis in humans [2] Many intestinal Helicobacter spp., however, do not have a clearly defined role in pathogenesis. One example is Helicobacter muridarum, which was initially described as a member of the normal flora of conventional rodents [6]. Subsequent studies, however, showed that H. muridarum could induce colitis and gastritis in mice, suggesting a potentially pathogenic role for the bacterium [7], [8], [9].
Intestinal epithelial cells have long been considered to act as a physical barrier that protects the integrity of epidermal or mucosal surfaces. A growing body of evidence now suggests an active role for these cells in host defense. Indeed, intestinal epithelial cells express several types of transmembrane pathogen recognition molecule (PRM) [10], [11]. Among the best characterized of these molecules are Toll-like receptor 2 (TLR2), which recognizes lipoprotein/lipoteichoic acid as well as atypical forms of lipopolysaccharide (LPS) [12], [13], and TLR4, which responds to the classical forms of Gram-negative LPS, such as that of Escherichia coli. Although PRMs are thought to play a crucial role in host immune responses to microbial pathogens, the mechanisms by which such molecules discriminate between pathogenic organisms and the host commensal microflora remain unclear. Unrestrained activation of intestinal innate immune molecules by micro-organisms plays a fundamental role in the pathophysiology of IBD [14].
In addition to the TLRs, a family of intracytoplasmic PRMs with homology to plant resistance proteins, known as the NOD-like receptors (NLRs) [15], has been described. Two members of this family, NOD1 (or CARD4) and NOD2 (or CARD15), were reported to respond to peptidoglycan, a component of bacterial cell walls [16], [17]. NOD1 displayed a high specificity for Gram-negative peptidoglycan [18]. Moreover, this molecule was implicated in epithelial cell responses to a variety of gastrointestinal bacteria, including the gastric pathogen Helicobacter pylori [15].
Host cell recognition of micro-organisms or their products via PRMs is known to initiate pro-inflammatory signaling events that converge on the transcription factor, nuclear factor-κB (NF-κB), culminating in up-regulated cytokine/chemokine gene expression in cells. Epithelial cell-derived CXC chemokines, such as CXCL8 (or interleukin-8), are critical mediators in the development of local inflammation in human IBD [19]. Mice do not possess a homolog of CXCL8, and produce instead Cxcl1 (KC) and Cxcl2 (MIP-2); these two chemokines are the major promoters of leukocyte recruitment in murine tissues [20], [21].
While the pathophysiology of Helicobacter-induced colitis in mouse models is well characterized, the inflammatory mediators and PRMs involved in the development of inflammation in these models is still poorly understood. We sought to address this question by studying NF-κB and/or CXC chemokine responses in epithelial cell lines stimulated with a selection of intestinal Helicobacter spp. This work has allowed us to identify, for the first time, the contribution of two PRMs, TLR2 and NOD1, in innate immune recognition of a commensal Helicobacter sp. of the normal rodent flora.
Results
Enterohepatic Helicobacter spp. induce CXC chemokine synthesis in murine intestinal epithelial cells
The effect of murine Helicobacter spp. on pro-inflammatory cytokine production in epithelial cells was evaluated in the mouse small intestinal cell line, m-ICcl2 [22]. For the purposes of this study, we chose two pathogenic species, H. bilis and H. hepaticus [3], [4], [5], and one species of ill-defined pathogenicity, H. muridarum.
All three Helicobacter spp. induced increases in gene expression of the CXC chemokines, Cxcl1 and Cxcl2 (Figure 1A and 1B). Cxcl1 and Cxcl2 mRNA levels were maximal at 18 h post-stimulation and were greatest in cells stimulated with either H. bilis ATCC51630 or H. muridarum ATCC49282. The levels of Cxcl1 and Cxcl2 steadily increased over time in Helicobacter-stimulated m-ICcl2 cells, with maximal levels present at between 48 and 72 h post-stimulation (Figure 1C and 1D). In agreement with the mRNA data, H. muridarum ATCC49282 and H. bilis ATCC51630 consistently induced 5- to 10-fold greater quantities of Cxcl1 and Cxcl2 production when compared to H. hepaticus ATCC51448. Interestingly, Sterzenbach and colleagues [23] also reported poor responses of m-ICcl2 cells to stimulation with live H. hepaticus. As previously described for LPS-stimulation [11], stimulation with Helicobacter bacteria did not appear to induce interleukin-6 nor tumor necrosis factor production in m-ICcl2 cells (data not shown).
Cell contact-dependent chemokine responses in murine epithelial cells to live H. muridarum bacteria
Given that H. muridarum induced consistently high levels of chemokine production in m-ICcl2 cells, and that its potential pathogenicity is poorly understood, we chose to further investigate the interactions of this Helicobacter sp. with epithelial cells. The first aim was to determine the role of cell-cell contact in H. muridarum induction of CXC chemokine synthesis in m-ICcl2 cells. The separation of H. muridarum ATCC49282 bacteria from m-ICcl2 cells by Transwell filter membranes was found to completely abrogate the Cxcl1 and Cxcl2 responses observed at 48 h post-incubation (Figure 2). Moreover, increasing the numbers of Transwell-separated H. muridarum bacteria to ten times those required in direct contact assays did not augment CXC chemokine production in the cells (Figure 2). These data demonstrated that direct bacterial-cell contact was required for epithelial cell responses at 48 h post-incubation with H. muridarum ATCC49282. Furthermore, the data suggest that it is unlikely that the responses observed at ≥48 h could be mediated by bacterial products released during bacterial lysis, as these products would not be retained by Transwell filters. In which case, the filters should not have had any effect on chemokine production by the cells.
H. muridarum LPS induces pro-inflammatory responses in epithelial cells
It was previously reported that m-ICcl2 cells produce Cxcl2 in response to stimulation with E. coli LPS [11]. We therefore wished to determine whether H. muridarum LPS could induce similar responses in this cell line. Indeed, 0.1 µg/ml of highly purified H. muridarum ATCC49282 LPS was sufficient to induce a significant increase in Cxcl1 and Cxcl2 production in m-ICcl2 cells (P<0.0001; Figure 3A), with maximal responses detected at 24 h post-stimulation (Figure 3B and 3C). Interestingly, in contrast to the findings for purified LPS, live H. muridarum ATCC49282 bacteria induced significantly higher levels of Cxcl1 and Cxcl2 at the later time-points of 48 and 72 h (P = 0.0002 and P<0.0001; and P<0.0001 and P<0.0001, respectively; Figure 3B and 3C). Thus, the data suggested a biphasic pattern of responses in m-ICcl2 cells to H. muridarum.
Given that LPS appeared to be the key agonist involved in the early chemokine responses of m-ICcl2 cells to H. muridarum stimulation, we wished to determine the PRM involved in sensing of H. muridarum LPS. Using human embryonic kidney (HEK293) cell lines stably expressing either TLR2 or TLR4, we were able to show dose-dependent CXCL8 responses to H. muridarum ATCC49282 and H. pylori NCTC11637 LPS only in the TLR2-expressing cells (Figure 4). E. coli 0111:B4 LPS was used as a control in these experiments. As expected, HEK293 cells expressing exogenous TLR4 responded to this classical form of Gram-negative LPS, whereas no significant responses were detected in HEK293 cells, which are naturally deficient in either TLR2 or TLR4 [18], [24], nor in those expressing exogenous TLR2. As m-ICcl2 cells were shown to be responsive to the TLR2 agonist, Pam-3-Cys [11], it is likely that TLR2 was responsible for the early responses of these cells to H. muridarum LPS.
Live H. muridurum bacteria induce NOD1-dependent responses in HEK293 and AGS cells
The studies in m-ICcl2 cell line suggested that an LPS-independent mechanism was likely to mediate the late chemokine responses to live H. muridarum bacteria (Figure 3B and 3C). To address this question, we used HEK293 cells which are naturally deficient in TLR2 and TLR4 expression [18]. As the HEK293 cell line is of human origin, we included in these experiments the human intestinal Helicobacter isolates, H. cinaedi and H. fennelliae.
H. muridarum ATCC49282 induced a significant increase in NF-κB reporter activity in HEK293 cells, when compared to unstimulated cells (Figure 5A; P<0.05). Similar to the findings for the m-ICcl2 cell line, HEK293 responses to live H. muridarum were cell contact-dependent (Figure 5A). These responses could not, however, be attributed to the invasive properties of H. muridarum as this bacterium was found to be no more invasive than either H. bilis or H. hepaticus (Figure S1). Strikingly, the various other intestinal Helicobacter spp. tested here, including the human isolates H. cinaedi ATCC35683 and H. fennelliae ATCC35684, were very weak inducers of NF-κB reporter activity in HEK293 cells (Figure 5A).
HEK293 cells are able to respond to bacterial pathogens via the cytosolic PRM, NOD1 [15]. As H. pylori strains carrying a functional type IV secretion apparatus (T4SS) were shown to trigger NOD1 signaling in these cells [25], [26], we co-cultured HEK293 cells with either H. muridarum ATCC49282, or H. pylori bacteria possessing or not a functional T4SS (strains 26695 and SS1, respectively) [26]. H. muridarum ATCC49282 was found to induce similar levels of NF-κB-dependent reporter activity, albeit at a slower rate, than H. pylori bacteria with a functional T4SS (strain 26695; Figure 5B). Consistent with the NF-κB reporter studies, H. muridarum also up-regulated CXCL8 synthesis in HEK293 cells (Figure 5C). Transfection of these cells with increasing concentrations of a dominant-negative NOD1 construct, in which the caspase activation recruitment domain (CARD) was deleted [27], significantly abrogated H. muridarum effects on NF-κB reporter activity (Figure 5D; P<0.05). Furthermore, we demonstrated that AGS cells stably expressing siRNA to NOD1 produced significantly less CXCL8 in response to stimulation with H. muridarum (or H. pylori), when compared to cells expressing siRNA to an irrelevant control gene (Figure 5E; P = 0.002). The abrogation of NOD1 signaling by ΔCARD NOD1 or NOD1 siRNA resulted in comparable decreases in cell responses to either H. muridarum ATCC49282 or T4SS-positive H. pylori. Thus, the data suggested that NOD1 was important for epithelial cell responses to H. muridarum. As m-ICcl2 cells express NOD1 mRNA ([23]; Figure S2), we propose that NOD1 contributed to the LPS-independent responses to live H. muridarum bacteria in this cell line (Figure 3B and 3C). To exclude a role for NOD1 in the observed responses of m-ICcl2 cells to purified H. muridarum LPS (Figure 3), we delivered the purified material into the cytosol of HEK293 cells, together with NOD1-expressing construct, using a previously described liposome-based technique [18], [26]. Transfection of cells with H. muridarum ATCC49282 LPS was shown to have no effect on NF-κB activity, whereas H. pylori 26695 peptidoglycan transfected in this way induced a significant response (Figure S3). This suggests that the H. muridarum LPS preparation was devoid of peptidoglycan muropeptides, which might otherwise induce NOD1 signaling in m-ICcl2 cells. It also suggests that the observed activity of H. muridarum LPS activity on TLR2 signaling (Figure 4) could not be ascribed to lipoprotein contamination of this LPS preparation.
Although the data strongly suggested that NOD1 is a key PRM involved in epithelial cell responses to H. muridarum, HEK293 and AGS cells both also express the PRM for bacterial flagellin, TLR5 [26], [28]. All Helicobacter spp. are flagellated and it was therefore possible that this PRM may be involved in the cell responses to H. muridarum. To examine this suggestion, we sequenced a region of the gene encoding the major flagellin subunit (FlaA) of H. muridarum ATCC49282 (Figure 5F). We demonstrated that H. muridarum FlaA does not possess any of the eight highly conserved amino acid residues, corresponding to residues 89–96 of Salmonella typhimurium FliC, which have been found to be required for activation of TLR5 by bacterial flagellins [29], [30], [31]. Instead, the corresponding region of H. muridarum FlaA displayed a high degree of conservation with the FlaA homologs of gastric and intestinal Helicobacter spp. which are known to evade TLR5 recognition [23], [29], [30]. These findings, together with the lack of a systematic responsiveness of epithelial cells to other flagellated Helicobacter spp. (Figure 5A; [23], [29]), also allow us to formally exclude TLR5 as playing a significant role in H. muridarum recognition.
Discussion
Enterohepatic Helicobacter spp. have been reported to induce chronic intestinal inflammation in animal hosts [2], [3], [7]. The role of these bacterial species in the development of intestinal inflammation is, however, poorly understood. By studying epithelial cell responses to various enterohepatic Helicobacter spp. of murine and human origin, we showed that H. muridarum, an isolate from the normal intestinal flora of conventional rodents [6], [9], was capable of inducing CXC chemokine production and NF-κB activation in epithelial cells in vitro. Collectively, this bacterium was found to be a more potent inducer of pro-inflammatory responses in mouse and human cell lines than either of the two mouse pathogens, H. bilis or H. hepaticus. Epithelial cell responses to H. muridarum were mediated by both LPS-dependent and -independent mechanisms. We propose that the intracellular PRM, NOD1, participates in the LPS-independent responses to H. muridarum. While there have been several reports concerning NOD1 signaling to gastrointestinal pathogens [15], this is the first describing the involvement of this molecule in epithelial cell responses to a member of the normal microbial flora.
H. muridarum was originally cultivated from the ileal and cecal tissues of conventional rodents [6]. H. muridarum was also reported to colonize the gastric mucosa of aged conventional mice, and to induce gastritis in these animals [8], [9]. Moreover, mice that were monoassociated with H. muridarum displayed an accelerated development of IBD-like lesions in a CD45RBhigh CD4+ T cell transfer model of experimental colitis [7]. Hence, it was suggested that the bacterium was a “provocateur” of IBD [7]. Consistent with this suggestion, H. muridarum was shown here to induce robust pro-inflammatory responses in epithelial cells of human and mouse origins. Co-culture of m-ICcl2 mouse intestinal cells with H. muridarum resulted in increased transcription and synthesis of two CXC chemokines, Cxcl1 and Cxcl2. These chemokines are key promoters of polymorphonuclear leukocyte recruitment in mice [20], [21] and may thus represent important mediators of the inflammatory responses observed in Helicobacter colitis models.
The m-ICcl2 cell line synthesizes functional TLR2 and TLR4 molecules [11], [23]. Stimulation of these cells with either TLR2 or TLR4 ligands (Pam-3-Cys and LPS, respectively) resulted in increased NF-κB-dependent pro-inflammatory cytokine production [11], [32]. In the current study, we demonstrated a dose-dependent effect of H. muridarum LPS on Cxcl1 and Cxcl2 synthesis in m-ICcl2 cells (Figure 3A). These responses appear to depend on TLR2 recognition of this LPS (Figure 4). Interestingly, as found here (Figure 4B) and elsewhere [12], [13], H. pylori LPS also seems to signal via TLR2, however the situation is not clear as other researchers have claimed TLR4 to be the cognate PRM for this LPS molecule [33]. These differences may be attributed to the experimental conditions (e. g. LPS concentrations) used in the various studies.
Although m-ICcl2 cells were highly responsive to H. muridarum LPS, the kinetics and magnitude of these responses were different to those induced by live bacteria (Figure 3B and 3C). This finding suggested the existence of an LPS-independent mechanism in epithelial cell signaling to H. muridarum. Further experiments were undertaken in the HEK293 and AGS cell lines, neither of which express functional TLR2 nor TLR4 [18]. Of the five murine and human Helicobacter spp. tested, only H. muridarum had a dramatic effect on NF-κB reporter activity in HEK293 cells (Figure 5A). Preliminary studies with three other H. muridarum strains suggest that it may be a strain-independent phenomenon (data not shown). Although H. bilis, and to a lesser extent, H. hepaticus, induced CXC chemokine production in m-ICcl2 cells, these species were poor agonists of NF-κB responses in HEK293 cells. Taken together, the findings highlight the specific nature of HEK293 cell responses to H. muridarum. Moreover, responses to H. muridarum were demonstrated to be NOD1-dependent and TLR5-independent (Figure 5). The latter finding is consistent with the conclusions of several studies reporting that TLR5 is not important for epithelial cell recognition of Helicobacter spp. [23], [29], [30].
The present work raises two important questions relating to the bacterial pathogenesis of enterohepatic Helicobacter spp. The first of these concerns the mechanism by which H. muridarum may trigger NOD1 signaling in epithelial cells. NOD1 responds specifically to Gram-negative peptidoglycan presented within the cytoplasm of epithelial cells by pathogenic bacteria. Until now, this has been reported to occur via either cell invasion or by the actions of a bacterial T4SS, encoded by the H. pylori cag pathogenicity island (PAI) [15]. H. muridarum, however, does not appear to be any more invasive than other Helicobacter spp (Figure S1) [26], and does not harbor the genes needed to encode a functional T4SS (RLF, unpublished data). Thus, H. muridarum is likely to utilize a different mechanism of peptidoglycan delivery than those described previously. This suggestion would be consistent with the relatively longer incubation periods (>24 h) required for H. muridarum-induced NF-κB reporter activity in HEK293 cells, when compared to those used for the T4SS-positive H. pylori 26695 strain (≤4 h; Figure 5B). In AGS cells, however, a 1 h contact time with cells was sufficient for the induction of responses by H. muridarum, whereas this was insufficient for H. pylori 251cagPAI, a T4SS-deficient mutant (Figure 5E). Nevertheless, when compared to T4SS-positive H. pylori, 10-fold more H. muridarum bacteria (MOI 1∶100) were required to induce comparable responses in these cells, suggesting that H. muridarum is a less efficient initiator of NOD1 signaling. These findings point towards the existence in H. muridarum of an alternative mechanism for activation of the NOD1 pathway.
A second question arising from the work relates to the low pro-inflammatory activity of H. hepaticus on epithelial cell lines. Although this bacterium has been shown to induce colitis in certain strains of mice [4], [5], one study reported that germ-free IL-10−/− mice monoassociated with H. hepaticus (the same strain as the one used here) did not develop colitis [34]. It is thus possible that the presence of a complex intestinal flora may promote the virulence potential of H. hepaticus. It has also been suggested that the level of pathogenicity exhibited by different H. hepaticus isolates may be strongly influenced by strain-specific differences in gene content, including the presence or otherwise of a complete PAI [35], [36]. Conversely, there have been reports that under certain circumstances H. hepaticus is able to dampen inflammation [37]. Consistent with this suggestion, Sterzenbach et al. showed that m-ICcl2 cells that had been pre-incubated with H. hepaticus cell lysates, responded poorly to TLR4 and TLR5 agonists [23]. Nevertheless, both that work as well as our own were performed in relatively simple epithelial cell models that mimic only a small aspect of the complex interactions occurring between host cells and intestinal pathogens or commensals. Thus, even if H. hepaticus may be able to down-regulate pro-inflammatory responses in epithelial cells, it is plausible that its interactions with other mucosal cell populations and/or other components of the host microflora may contribute to the inflammation normally associated with infection by this bacterium.
Mazmanian and colleagues [38] hypothesized that intestinal inflammation may be caused by imbalances between commensal organisms that have a pathogenic potential (so-called “pathobionts”) and those with beneficial potential (“symbionts”). From the evidence presented here, it appears that H. muridarum has a pathogenic potential and should therefore be considered a pathobiont. This observation has practical consequences for those who work with rodent models of inflammation and immunity. Indeed, H. muridarum may be “missed” by the assays commonly employed to monitor the specific pathogen-free (SPF) status of animals. Furthermore, although some laboratory animal suppliers use Helicobacter genus-specific PCR assays to verify the SPF status of their animals, this is not always the case. H. muridarum (or indeed other poorly studied Helicobacter spp.) may therefore have a confounding effect in mouse colitis models, particularly as H. muridarum was shown to engage TLR2 and NOD1, both of which are expressed in intestinal epithelial cells [11], [23], [39], [40]. Given that defects in TLR and/or NLR signaling are thought to affect the ability of host cells to respond normally to the intestinal microflora, it is plausible that these together with imbalances within the flora may contribute to the development of inflammatory conditions in the gut. Further investigations should thus be undertaken to elucidate the role of PRMs in epithelial cell sensing of members of the normal microflora.
Materials and Methods
Bacteria
H. bilis (CIP204753T, ATCC51630), H. cinaedi (CIP103752T, ATCC35683); H. hepaticus (ATCC51448), H. fennelliae (ATCC35684); and H. muridarum (St1, ATCC49282) were kindly provided by the Culture Collection of the Institut Pasteur (Paris, France), Prof. J. G. Fox (Massachusetts Institute of Technology, Boston, MA) and Dr J. O'Rourke (The University of NSW, Sydney, Australia), respectively. H. pylori 26695, SS1, and 251 strains were as described previously [26]. The H. pylori 251 cagPAI deletion mutant was constructed by natural transformation using the kanamycin resistance cassette developed by Odenbreit et al. [41].
Bacteria were routinely subcultured on Blood Agar Base No. 2 (Oxoid, Hampshire, UK), supplemented with 8–10% horse blood and an antibiotic cocktail [26]. Broth cultures were prepared in 10 ml Brain Heart Infusion (Oxoid) containing 10% heat-inactivated fetal calf serum (FCS; Invitrogen, Cergy-Pontoise, France and Auckland, New Zealand) [26]. Bacterial suspensions were washed three times in phosphate-buffered saline (pH 7.4), then resuspended in cell culture medium. Viable counts of the bacterial suspensions were determined by serial plating [26]. Highly purified H. muridarum ATCC49282 and H. pylori NCTC11637 LPS were prepared by hot phenol-water extraction and subsequent enzymatic treatments with DNase, RNase and proteinase K (Sigma Chemical Co., St Louis, MO) and by ultracentrifugation [42]. E. coli 0111:B4 Ultrapure LPS was obtained from InvivoGen (Toulouse, France).
Cell culture conditions
The murine m-ICcl2 epithelial cell line represents a clone of immortalized cells that were derived from the bases of small intestinal villi of transgenic mice [22]. These cells were routinely grown in a supplemented DMEM-F12 medium (Invitrogen) [22]. Diluted cell suspensions were seeded onto collagen-coated (2 mg/ml rat tail collagen type 1, Sigma) culture plates, and incubated at 37°C in 5% CO2. For co-culture experiments, m-ICcl2 cells were grown for 1 day then serum-starved overnight. The cells were washed three times in DMEM-F12 medium, and re-incubated in antibiotic-free, serum-free medium, prior to addition of the bacteria or purified H. muridarum LPS. Culture supernatants were collected at the indicated times and frozen at −80°C until assayed.
HEK293 cells, as well as the TLR2- and TLR4-expressing HEK293 cell lines [43], were grown routinely in DMEM (Invitrogen) containing 10% FCS, and incubated at 37°C in 5% CO2 [25]. Bacteria were separated from epithelial cells using 0.2 µm Transwell filters (Corning Incorporated, Corning, NY). Helicobacter and E. coli LPS (0.01–1.0 µg) were added directly to HEK293 cells and the culture supernatants collected 8 h later.
AGS cells were routinely cultured in serum-supplemented RPMI 1640 cell culture media [25]. The AGS control siRNA and NOD1 siRNA cells were generated by integration of an expression vector containing a small interference RNA (siRNA) directed to either the gene encoding enhanced green fluorescent protein (EGFP) or the CARD of the NOD1 gene, respectively. A detailed description and characterization of these cell lines is given elsewhere (Grubman et al.; manuscript submitted). For co-culture assays, bacteria were added for 1 h to serum-starved cells (MOI 1∶10 for H. pylori and 1∶100 for H. muridarum), washed off, and the media replaced. Culture supernatants were collected 17–23 h later.
Cell transfection assays
HEK293 cells were plated in 24-well plates at a density of 1×105 cells and transfected the following day with Igκ-luciferase reporter DNA, using FuGene6 reagent medium (Roche Diagnostics, Meylan, France) [44]. For dominant-negative studies, cells were co-transfected with ΔCARD NOD1 DNA [27]. The transfected cells were incubated overnight and co-cultured with live bacteria (MOI = 1∶10 to 1∶100) for 2–24 h, prior to lysis of the cells [26]. Lysed cells were assayed for luciferase activities using a 96-well luminometer.
Reverse Transcriptase–PCR (RT–PCR)
Total RNA was isolated from epithelial cells using TRIzol reagent (Invitrogen). RNA (1 mg) from each sample was reverse-transcribed using 25 U of superscript II reverse transcriptase (Invitrogen). PCR was conducted using 2 ml of cDNA and 0.25 U Taq DNA polymerase (Amersham Biosciences, Orsay, France). Fifteen pmol each of 5′ and 3′ primers for cytokine genes were used with 3 pmol each of β-actin primers in a multiplex reaction. One PCR cycle consisted of the following: 94°C for 1 min, 64°C for 1 min 15 s, and 72°C for 1 min 15 s. The total cycle numbers were 35. A final elongation step of 7 min at 72°C was then used. Primer sequences were as follows: murine Cxcl1, [45], 5′-TTGAAGGTGATGCCGCCAG-3′ and 5′-CCCAGACTCTCATCTCTCC-3′; murine Cxcl2, [46], 5′-CATCGAATTCGGCAGACTCCAGCCACACTTCAGCCT-3′ and 5′-GATCGGATCCGGCAGTTAGCCTTGCCTTTGTTCAGT-3′; murine β-actin (ActB), 5′-CCAGAGCAAGAGAGGTATCC-3′ and 5′-CTGTGGTGGTGAAGCTGTAG-3′. PCR products (with sizes of 205, 358 and 436 bp, respectively) were separated on 1.5% agarose gels with 0.4 mg/ml ethidium bromide. Stained bands were visualized under UV light, and photographed with an Image Master VDS machine (Amersham).
PCR amplification of H. muridarum flaA
PCR was performed on genomic DNA (1–10 ng) that had been purified from H. muridarum using the MasterPure™ DNA Purification Kit (EPICENTRE Biotechnologies, Madison, WI). DNA samples from H. pylori 26695 and H. hepaticus ATCC51448 were used as positive controls. The PCR samples contained 20 µM of each primer, 200 µM of total dNTPs (Promega, Alexandria, NSW, Australia), 0.5 U Taq Polymerase Taq and buffer (both from Roche Applied Science, Castle Hill, NSW, Australia). One PCR cycle consisted of the following: 94°C for 1 min, 50°C for 1 min, and 72°C for 1 min 15 s. The total cycle numbers were 30. A final elongation step of 7 min at 72°C was used. Primer sequences were as follows: oligo A, 5′-ATGGCTTTTCAGGTCAATAC-3′; oligo C, 5′-CCTACTTGGAATTCTTTG-3′. PCR products (449 bp) were separated on 1.5% agarose gels, as above, and the DNA purified using the Perfectprep Gel Cleanup kit (Eppendorf North Ryde, NSW, Australia). DNA sequencing of the H. muridarum flaA amplicon was performed by Micromon Services (Monash University, Clayton, VIC, Australia) using BigDye Terminator Cycle Sequencing (Applied Biosystems, Scoresby, VIC, Australia). The deduced H. muridarum FlaA sequence was aligned with those of S. typhimurium FliC and the FlaA homologs of other Helicobacter spp. using CLUSTALW software (http://www.ebi.ac.uk/Tools/clustalw2/index.html).
Chemokine assays
CXC chemokine (Cxcl1, Cxcl2 or CXCL8) levels were determined from culture supernatants using cytokine enzyme-linked immunosorbent assay (ELISA) kits from either R&D Systems (Minneapolis, MN) or BD Pharmingen (CA).
Statistical analysis
Data were analyzed using the Student's t-test and Mann-Whitney test, as appropriate. Differences in data values were considered significant for P≤0.05.
Supporting Information
Acknowledgments
Dr. A. Vandewalle (Hôpital Xavier Bichat, Paris, France) is gratefully acknowledged for supplying the m-ICcl2 epithelial cell line. Drs. A. Mansell (Monash Institute for Medical Research, Monash University, Clayton, Australia) and D. Golenbock (School of Medicine, University of Massachusetts, Worcester, MA) are thanked for provision of the TLR-expressing HEK293 cells.
Footnotes
Competing Interests: The authors have declared that no competing interests exist.
Funding: NCD was supported by research scholarships from the Association Francois Aupetit (France). This work was funded by the Association Francois Aupetit (RLF); the Institut Pasteur, Paris (PTR 94 project No. 80944 to DJP and RLF); the Association pour la Recherche sur le Cancer (ARC project no. 4428 to RLF); the National Health and Medical Research Council (project grant no. 334127 to RLF); and the Health Research Board, Ireland (APM). DJP is an International Research Scholar of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol. 1999;11:648–656. doi: 10.1016/s0952-7915(99)00032-1. [DOI] [PubMed] [Google Scholar]
- 2.Ferrero RL, Fox JG. In vivo modeling of Helicobacter-associated gastrointestinal diseases. In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: Physiology and genetics. Washington D. C.: ASM Press; 2001. pp. 565–582. [PubMed] [Google Scholar]
- 3.Shomer NH, Dangler CA, Schrenzel MD, Fox JG. Helicobacter bilis induced inflammatory bowel disease (IBD) in defined flora scid mice. Infect Immun. 1997;65:4858–4864. doi: 10.1128/iai.65.11.4858-4864.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Cahill RJ, Foltz CJ, Fox JG, Dangler CA, Powrie F, et al. Inflammatory bowel disease: an immune mediated condition triggered by bacterial infection with Helicobacter hepaticus. . Infect Immun. 1997;65:3126–3131. doi: 10.1128/iai.65.8.3126-3131.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun. 1998;66:5157–5166. doi: 10.1128/iai.66.11.5157-5166.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Phillips MW, Lee A. Isolation and characterization of a spiral bacterium from the crypts of rodent gastrointestinal tracts. Appl Environ Microbiol. 1983;45:675–683. doi: 10.1128/aem.45.2.675-683.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Jiang HQ, Kushnir N, Thurnheer MC, Bos NA, Cebra JJ. Monoassociation of SCID mice with Helicobacter muridarum, but not four other enterics, provokes IBD upon receipt of T cells. Gastroenterology. 2002;122:1346–1354. doi: 10.1053/gast.2002.32959. [DOI] [PubMed] [Google Scholar]
- 8.Lee A, Chen M, Coltro N, O'Rourke J, Hazell S, et al. Long term infection of the gastric mucosa with Helicobacter species does induce atrophic gastritis in an animal model of Helicobacter pylori infection. Zentralbl Bakteriol. 1993;280:38–50. doi: 10.1016/s0934-8840(11)80939-4. [DOI] [PubMed] [Google Scholar]
- 9.Queiroz DM, Contigli C, Coimbra RS, Nogueira AM, Mendes EN, et al. Spiral bacterium associated with gastric, ileal and caecal mucosa of mice. Lab Anim. 1992;26:288–294. doi: 10.1258/002367792780745760. [DOI] [PubMed] [Google Scholar]
- 10.Cario E, Brown D, McKee M, Lynch-Devaney K, Gerken G, et al. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Pathol. 2002;160:165–173. doi: 10.1016/S0002-9440(10)64360-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hornef MW, Frisan T, Vandewalle A, Normark S, Richter-Dahlfors A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med. 2002;195:559–570. doi: 10.1084/jem.20011788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Smith MF, Jr, Mitchell A, Li G, Ding S, Fitzmaurice AM, et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem. 2003;278:32552–32560. doi: 10.1074/jbc.M305536200. [DOI] [PubMed] [Google Scholar]
- 13.Triantafilou M, Gamper FG, Lepper PM, Mouratis MA, Schumann C, et al. Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell Microbiol. 2007;9:2030–2039. doi: 10.1111/j.1462-5822.2007.00935.x. [DOI] [PubMed] [Google Scholar]
- 14.MacDonald TT, Pettersson S. Bacterial regulation of intestinal immune responses. Inflamm Bowel Dis. 2000;6:116–122. doi: 10.1097/00054725-200005000-00008. [DOI] [PubMed] [Google Scholar]
- 15.Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol. 2006;7:1250–1257. doi: 10.1038/ni1412. [DOI] [PubMed] [Google Scholar]
- 16.Girardin SE, Sansonetti PJ, Philpott DJ. Intracellular vs extracellular recognition of pathogens–common concepts in mammals and flies. Trends Microbiol. 2002;10:193–199. doi: 10.1016/s0966-842x(02)02334-x. [DOI] [PubMed] [Google Scholar]
- 17.Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem. 2003;278:5509–5512. doi: 10.1074/jbc.C200673200. [DOI] [PubMed] [Google Scholar]
- 18.Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science. 2003;300:1584–1587. doi: 10.1126/science.1084677. [DOI] [PubMed] [Google Scholar]
- 19.Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, et al. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol. 1994;144:997–1007. [PMC free article] [PubMed] [Google Scholar]
- 20.Ohtsuka Y, Lee J, Stamm DS, Sanderson IR. MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut. 2001;49:526–533. doi: 10.1136/gut.49.4.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Remick DG, Green LB, Newcomb DE, Garg SJ, Bolgos GL, et al. CXC chemokine redundancy ensures local neutrophil recruitment during acute inflammation. Am J Pathol. 2001;159:1149–1157. doi: 10.1016/S0002-9440(10)61791-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Bens M, Bogdanova A, Cluzeaud F, Miquerol L, Kerneis S, et al. Transimmortalized mouse intestinal cells (m-ICcl2) that maintain a crypt phenotype. Am J Physiol (Cell Physiol) 1996;270:C1666–1674. doi: 10.1152/ajpcell.1996.270.6.C1666. [DOI] [PubMed] [Google Scholar]
- 23.Sterzenbach T, Lee SK, Brenneke B, von Goetz F, Schauer DB, et al. Inhibitory effect of enterohepatic Helicobacter hepaticus on innate immune responses of mouse intestinal epithelial cells. Infect Immun. 2007;75:2717–2728. doi: 10.1128/IAI.01935-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kurt-Jones EA, Sandor F, Ortiz Y, Bowen GN, Counter SL, et al. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity. J Endotoxin Res. 2004;10:419–424. doi: 10.1179/096805104225006516. [DOI] [PubMed] [Google Scholar]
- 25.Philpott DJ, Belaid D, Troubadour P, Thiberge JM, Tankovic J, et al. Reduced activation of inflammatory responses in host cells by mouse-adapted Helicobacter pylori isolates. Cell Microbiol. 2002;4:285–296. doi: 10.1046/j.1462-5822.2002.00189.x. [DOI] [PubMed] [Google Scholar]
- 26.Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5:1166–1174. doi: 10.1038/ni1131. [DOI] [PubMed] [Google Scholar]
- 27.Bertin J, Nir WJ, Fischer CM, Tayber OV, Errada PR, et al. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappaB. J Biol Chem. 1999;274:12955–12958. doi: 10.1074/jbc.274.19.12955. [DOI] [PubMed] [Google Scholar]
- 28.Lee SK, Stack A, Katzowitsch E, Aizawa SI, Suerbaum S, et al. Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect. 2003;5:1345–1356. doi: 10.1016/j.micinf.2003.09.018. [DOI] [PubMed] [Google Scholar]
- 29.Andersen-Nissen E, Smith KD, Strobe KL, Rassoulian Barrett SL, Cookson BT, et al. Evasion of Toll-like receptor 5 by flagellated bacteria. PNAS USA. 2005;102:9247–9252. doi: 10.1073/pnas.0502040102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, et al. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis. 2004;189:1914–1920. doi: 10.1086/386289. [DOI] [PubMed] [Google Scholar]
- 31.Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol. 2003;4:1247–1253. doi: 10.1038/ni1011. [DOI] [PubMed] [Google Scholar]
- 32.Fernandez MI, Pedron T, Tournebize R, Olivo-Marin JC, Sansonetti PJ, et al. Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. Immunity. 2003;18:739–749. doi: 10.1016/s1074-7613(03)00122-5. [DOI] [PubMed] [Google Scholar]
- 33.Mandell L, Moran AP, Cocchiarella A, Houghton JM, Taylor N, et al. Intact Gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via Toll-like receptor 2 but not Toll-like receptor 4. Infect Immun. 2004;72:6446–6454. doi: 10.1128/IAI.72.11.6446-6454.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Dieleman LA, Arends A, Tonkonogy SL, Goerres MS, Craft DW, et al. Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect Immun. 2000;68:5107–5113. doi: 10.1128/iai.68.9.5107-5113.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Boutin SR, Shen Z, Rogers AB, Feng Y, Ge Z, et al. Different Helicobacter hepaticus strains with variable genomic content induce various degrees of hepatitis. Infect Immun. 2005;73:8449–8452. doi: 10.1128/IAI.73.12.8449-8452.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ge Z, Sterzenbach T, Whary MT, Rickman BH, Rogers AB, et al. Helicobacter hepaticus HHGI1 is a pathogenicity island associated with typhlocolitis in B6.129-IL10 tm1Cgn mice. Microbes Infect. 2008;10:726–733. doi: 10.1016/j.micinf.2008.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, et al. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am J Pathol. 2002;160:739–751. doi: 10.1016/S0002-9440(10)64894-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453:620–625. doi: 10.1038/nature07008. [DOI] [PubMed] [Google Scholar]
- 39.Hisamatsu T, Suzuki M, Podolsky DK. Interferon-gamma augments CARD4/NOD1 gene and protein expression through interferon regulatory factor-1 in intestinal epithelial cells. J Biol Chem. 2003;278:32962–32968. doi: 10.1074/jbc.M304355200. [DOI] [PubMed] [Google Scholar]
- 40.Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, et al. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol. 2003;170:3977–3985. doi: 10.4049/jimmunol.170.8.3977. [DOI] [PubMed] [Google Scholar]
- 41.Odenbreit S, Gebert B, Puls J, Fischer W, Haas R. Interaction of Helicobacter pylori with professional phagocytes: role of the cag pathogenicity island and translocation, phosphorylation and processing of CagA. Cell Microbiol. 2001;3:21–31. doi: 10.1046/j.1462-5822.2001.00088.x. [DOI] [PubMed] [Google Scholar]
- 42.Moran AP, Helander IM, Kosunen TU. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol. 1992;174:1370–1377. doi: 10.1128/jb.174.4.1370-1377.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, et al. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem. 2002;277:47834–47843. doi: 10.1074/jbc.M207873200. [DOI] [PubMed] [Google Scholar]
- 44.Girardin SE, Tournebize R, Mavris M, Page AL, Li X, et al. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. . EMBO Rep. 2001;2:736–742. doi: 10.1093/embo-reports/kve155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Savard CE, Blinman TA, Choi HS, Lee SK, Pandol SJ, et al. Expression of cytokine and chemokine mRNA and secretion of tumor necrosis factor-alpha by gallbladder epithelial cells: response to bacterial lipopolysaccharides. BMC Gastroenterol. 2002;2:23. doi: 10.1186/1471-230X-2-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Garhart CA, Heinzel FP, Czinn SJ, Nedrud JG. Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent. Infect Immun. 2003;71:910–921. doi: 10.1128/IAI.71.2.910-921.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.